While rituximab appeared to be the most effective treatment across studies, this observation did not reach statistical significance.
← all excerpts
Effect of targeted therapies on pulmonary function in rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis.
1
—
—